Literature DB >> 203869

Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.

L Pieri, H H Keller, W Burkard, M Da Prada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 203869     DOI： 10.1038/272278a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  23 in total

1.  Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome".

Authors:  E K Silbergeld; R E Hruska
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

Review 2.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

3.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

Review 4.  Classical dopamine agonists.

Authors:  R Horowski; P-A Löschmann
Journal:  J Neural Transm (Vienna)       Date:  2019-02-25       Impact factor: 3.575

5.  Visual hallucinosis: the major clinical determinant of distorted chromatic contour perception in Parkinson's disease.

Authors:  T Büttner; W Kuhn; T Müller; F L Welter; J Federlein; K Heidbrink; H Przuntek
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Drug discrimination procedures: differential characteristics of the drug A vs drug B and the drug A vs drug B vs no drug cases.

Authors:  M D Swedberg; T U Järbe
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Drug discrimination procedures: roles of relative stimulus control in two-drug cases.

Authors:  M D Swedberg; T U Järbe
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.

Authors:  S Chiu; R K Mishra
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

Review 9.  The pharmacology of Parkinson's disease: basic aspects and recent advances.

Authors:  M Da Prada; H H Keller; L Pieri; R Kettler; W E Haefely
Journal:  Experientia       Date:  1984-11-15

10.  Suppression of REM rebound by Pergolide.

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.